Blog

Operation Warp Speed Is Using A CIA-Linked Contractor To Keep Covid-19 Vaccine Contracts Secret

$6 billion in Covid-19 vaccine contracts awarded by Operation Warp Speed have been doled out by a secretive government contractor with deep ties to the CIA and DHS, escaping regulatory scrutiny and beyond the reach of FOIA requests.

Last Tuesday, while most Americans were distracted by the first US presidential debate, NPR quietly reported that the US government’s Operation Warp Speed, a public-private partnership launched by the Trump administration to rapidly develop and distribute a Covid-19 vaccine, had taken the unusual step of awarding contracts to vaccine companies, not directly, but through a secretive defense contractor.

Though NPR named thedefense contractor—South Carolina–based Advanced Technology International—they declined to explore the company’s deep ties to the CIA, Department of Homeland Security, and the Department of Defense and how ATI is helping to lead those agencies’ efforts to militarize health care and create a surveillance panopticon that not only monitors the world around us but our physiology as well.

The “secret” vaccine contracts awarded through ATI as part of Warp Speed total approximately $6 billion, accounting for the majority of Operation Warp Speed’s $10 billion budget. Both Paul Mango, Health and Human Services’ deputy chief of staff for policy, and Robert Kadlec, HHS assistant secretary for preparedness and response (ASPR), personally signed off on the contracts.

Operation Warp Speed, which officially involves the combined efforts of HHS and the military to deliver over 300 million Covid-19 vaccines to Americans by next January, is a highly secretive program dominated by military personnel, most of whom have no experience in health care or vaccine production. The Trump administration has often compared Warp Speed to the Manhattan Project, which produced the atomic bomb.

Several very unsettling revelations about the true nature and scope of Warp Speed, including the out-sized role of ATI, began to emerge starting last Monday. Yet, most of this new information was not covered by US news outlets due to the media frenzy surrounding the first presidential debate and the subsequent news that President Trump and several other politicians and White House officials had tested positive for Covid-19.

Keep reading

COVID-19 vaccine trial participants report aches, fevers and chills

Some participants for leading COVID-19 vaccine trials have reported experiencing grueling side effects after receiving the shot — such as high fever, body aches, headaches and exhaustion.

Five participants — three in Moderna’s study and two in Pfizer’s late-stage trials — said the uncomfortable side effects usually went away within a day, but some were surprised by how severe they were, CNBC reported.

“If this proves to work, people are going to have to toughen up,” one of the Moderna participants, a North Carolina woman in her 50s who declined to be identified, told the outlet.

“The first dose is no big deal. And then the second dose will definitely put you down for the day for sure. … You will need to take a day off after the second dose.”

She said she didn’t experience a fever but had a bad migraine that left her exhausted and struggling to focus, the outlet reported. But the next day, she woke up feeling better after taking Excedrin.

While she was uncomfortable, the side effects outweigh the risks of becoming infected with the virus, she said.

Keep reading